StockTipsArenaBeta

SELL Divi's Laboratories Limited — Kotak Securities

SELLDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byKotak SecuritiesHorizon: NA (inferred 1 year)3 Aug 2026via CNBC Awaaz.

Entry₹8,182.5Inferred
Target₹6,925
Total upside +15.37%
Stop lossNot given
CMP₹9,114Just now
Active-11.38%+24.02%upside left 10 mo left
Follow Kotak Securities for new calls(87% target hit, 15 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 6 other Long-term calls on DIVISLABSee 189 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 9:18 am IST
2 supporting14 neutral21 opposing
Supports the SELL call (2)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·3 Aug · 3mo ago

Neutral / worth noting (14)

Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in NSE's March 2027 index review

NewsEt-Markets·6 Oct · 2w ago

(opens in new tab)
Weighs against the SELL call (21)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·21 Oct · yesterday

Divi's Laboratories shares gain as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 2d ago

(opens in new tab)

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 3d ago

(opens in new tab)

Divi's FY26 net profit rises 17% to ₹2,568 crore

NewsGoogle News·26 Sept · 4w ago

(opens in new tab)

Divi's Laboratories recommends ₹30 dividend, outlines TDS compliance

NewsGoogle News·25 Sept · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Kotak Securities

Every call and its outcome